著者: ChenXiao-Wu, HeZhi-Xu, ZhouZhi-Wei, YangTianxin, ZhangXueji, YangYin-Xue, DuanWei, ZhouShu-Feng

原題: An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.

著者: NauckM A, EllisG C, FleckP R, WilsonC A, MekkiQ,

原題: Efficacy and safety of adding the dipeptidyl peptidase-4 inhibitor alogliptin to metformin therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicentre, randomised, double-blind, placebo-controlled study.

著者: Molina-GuarnerosJuan A, Sainz-GilMaría, Sanz-FadriqueRosario, GarcíaPilar, Rodríguez-JiménezPedro, Navarro-GarcíaEster, MartinLuis H

原題: Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases.

著者: BarnettAnthony H, CharbonnelBernard, MosesRobert G, KalraSanjay

原題: Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus.

著者: MiyoshiYuka, OgawaOsamu, NishidaAi, MasuzawaMasahiro

原題: Recurrent hyperglycemic hyperosmolar state after re-administration of dose-reduced ceritinib, an anaplastic lymphoma kinase inhibitor.

著者: LibiantoRenata, DavisTimothy Me, EkinciElif I

原題: Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes.

著者: MonamiM, DicembriniI, MannucciE

原題: Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials.

著者: GallwitzBaptist

原題: Novel Therapeutic Approaches in Diabetes.

著者: GhatakSomsuvra B, PatelDevang S, ShankerNeeraj, SrivstavaAmbrish, DeshpandeShrikalp S, PanchalShital J

原題: Alogliptin: a novel molecule for improving glycemic control in type II diabetes mellitus.

著者: JonesLauren, JonesAlan M

原題: Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?

著者: OguraToru, ShiraishiChihiro

原題: Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System.

著者: MonamiMatteo, DicembriniIlaria, MartelliDaniele, MannucciEdoardo

原題: Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials.

著者: ScheenA J

原題: [Alogliptin (Vipidia): a selective DPP-4 inhibitor with a good cardiovascular safety].

著者: ParsaKishore Vl, PalManojit

原題: Preclinical development of dipeptidyl peptidase IV inhibitor alogliptin: a brief overview.

著者: LiuY, HuY, LiuT

原題: Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects.

著者: ChengJudy W M, ColucciVincent J, KalusJames S, SpinlerSarah A

原題: Managing Diabetes and Preventing Heart Disease: Have We Found a Safe and Effective Agent?

著者: MpratsiakouAdamantia, PapasotiriouMarios, NtriniasTheodoros, TsiotsiosKonstantinos, PapachristouEvangelos, GoumenosDimitrios S

原題: Safety and Efficacy of Long-Term Administration of Dipeptidyl peptidase IV Inhibitors in Patients With New Onset Diabetes After Kidney Transplant.

著者: NakamuraYuya, InagakiMasahiro, ShimizuTatsuo, FujitaKiichiro, InoueMichiyasu, GotohHiromichi, OguchiKatsuji, GotoYoshikazu

原題: Long-term effects of alogliptin benzoate in hemodialysis patients with diabetes: a 2-year study.

著者: HeJian-Hua, ChenLi-Xia, LiHua

原題: Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets.

著者: BakshSheriza N, McAdams-DeMarcoMara, SegalJodi B, AlexanderG Caleb

原題: Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.

著者: DeaconC F, LebovitzH E

原題: Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.

著者: GuptaPrachi, BalaManju, GuptaSanjeev, DuaAnita, DaburRajesh, InjetiElisha, MittalAshwani

原題: Efficacy and risk profile of anti-diabetic therapies: Conventional vs traditional drugs-A mechanistic revisit to understand their mode of action.

著者: KalhotraPoonam, ChittepuVeera C S R, Osorio-RevillaGuillermo, Gallardo-VelazquezTzayhri

原題: Phytochemicals in Garlic Extract Inhibit Therapeutic Enzyme DPP-4 and Induce Skeletal Muscle Cell Proliferation: A Possible Mechanism of Action to Benefit the Treatment of Diabetes Mellitus.

著者: PalanisamySivanandy, YienEmily Lau Hie, ShiLing Wen, SiLow Yi, QiSee Hui, LingLaura Soon Cheau, LunTeng Wai, ChenYap Nee

原題: Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients.

著者: ShahMuhammad Ajmal, HarisMuhammad, FaheemHafiza Ishmal, HamidAyesha, YousafRimsha, RasulAzhar, ShahGhulam Mujtaba, KhalilAtif Ali Khan, WahabAbdul, KhanHaroon, AlhasaniReem Hasaballah, AlthobaitiNorah A

原題: Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity.